1. |
Damas J, Adam A, Remacle-Volon G, et al. Studies on the vascular and hematological changes induced by ellagic acid in rats. Agents Actions 1987; 22:270-9.
|
2. |
Wessler S, Yin ET. Experimental hypercoagulable state induced by factor X comparison of the nonactivated and activated forms. J Lab Clin Med 1968; 72:256-60.
|
3. |
Damas J, Remacle-Volon G, Adam A. Some cardiovascular and hematological changes induced in the rat by activa-tion of Hageman factor with ellagic acid. Adv Exp Med Biol 1989; 247:461-5.
|
4. |
Kosuge T, Ishida H, Yokota M, et al. Studies on anti-hemorrhagic substances in herbs classified as hemostatics in Chinese medicine. III. on the antihemorrhagic principle in Sanguisorba officinallis L. Chem Pharm Bull 1984; 32:4478-81.
|
5. |
Girolami A, Cella G, Burul A, et al. Failure of tranexamic acid to influence the ellagic acid-induced hypercoagulable state. Folia Haematol Int Mag Klin Morphol Blutforsch 1976; 103:261-70.
|
6. |
Iomhair MM, Lavelle SM. Effect of aspirin-dipyridamole and heparin and their combination on venous thrombosis in hypercoagulable or thrombosis animals. Thromb Res 1996; 82:479-83.
|
7. |
Shiozaki A, Niiya K, Higuchi F, et al. Ellagic acid/phos-pholipid-induced coagulation and dextran sulfate-induced fibrinolytic activities in beta 2-glycoprotein I-depleted plasma. Thromb Res 1994; 76:199-210.
|
8. |
Botti RE. Assessment of the hypercoagulable state and ellagic acid. Thromb Diath Haemorrh Suppl 1966; 20:49- 52.
|
9. |
Ratnoff OD, Saito H. The evolution of clot-promoting and amidolytic activities in mixtures of Hageman factor (factor XII) and ellagic acid. J Lab Clin Med 1982; 100:248-60.
|
10 |
Liu JT, Paul W, Powling MJ, et al. Sustained platelet en-trapment in rabbit pulmonary vasculature following ac-tivation of the intrinsic coagulation pathway with ellagic acid. Br J Pharmacol 1996; 119:194.
|
11 |
Dejana E, Villa S, Gaetano GD. Bleeding time in rats: a comparison of different experimental conditions. Thromb Haemost 1982; 48:108-11.
|
12 |
Wu KR. Hemostatics. In: Chen Q, editor. Methodology in pharmacological study on Chinese Materia Medica. 1st ed. Beijing: People’s Medical Publishing House; 1993. p. 484.
|
13 |
Quick AJ. The clinical application of hippuric acid and the prothrombin tests. Am J Clin Pathol 1940; 10:222-33.
|
14 |
Langdell RD, Wagner RH, Brinkhous KM. Effect of anti-hemophilic factor on one-stage clotting test; a presump-tive test for hemophilia and a simple one-stage antihe-mophilic factor assay procedure. J Lab Clin Med 1953; 41:637-47.
|
15 |
Wu KK, Hoak JC. A new method for the quantitative de-tection of platelet aggregates in patients with arterial insufficiency. Lancet 1974; 2:924-6.
|
16 |
Qiu PL, Wang MN. Effect of on the circulating platelet aggregation. Chin Tradit Herb Drugs 1983; 14:29-30.
|
17 |
Wen ZB, He SL, Zhang GS, et al. Hemostatic mechanisms & thrombosis. In: Li JZ, He SL, Wang HL, editors. Throm- botic disease theory. 1st ed. Beijing: Science and Tech-nology Publishing House; 1998. p. 1-14.
|
18 |
Botti RE, Ratnoff OD. Studies on the pathogenesis of thrombosis: An experimental hypercoagulable state in-duced by the intravenous injection of ellagic acid. J Lab Clin Med 1964; 64:385-98.
|
19 |
Girolami A, Agostino D, Cliffton EE. The effect of ellagic acid on coagulation in vivo. Blood 1966; 27:93-102.
|
20 |
Zhang QZ, Liu JT, Shi XL, et al. Effect of non-heating leech extract on coagulation system and platelet aggregation in the animal model of blood hypercoagulable state. Chin J Exp Tradit Med Form 2006; 12:47-9.
|